202 related articles for article (PubMed ID: 11123421)
1. The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(-) cases in Japanese population.
Kuze T; Nakamura N; Hashimoto Y; Sasaki Y; Abe M
Jpn J Cancer Res; 2000 Dec; 91(12):1233-40. PubMed ID: 11123421
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-positive Hodgkin/Reed-Sternberg-like B cell in non-hodgkin lymphoma: nucleotide sequence of the amplified immunoglobulin heavy-chain variable region gene by the single-cell polymerase chain reaction technique.
Nakamura N; Mori N; Ohshima K; Kuze T; Hashimoto Y; Sasaki Y; Shirakawa A; Sato M; Abe M
Diagn Mol Pathol; 2002 Jun; 11(2):83-9. PubMed ID: 12045711
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
4. Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern.
Delecluse HJ; Hummel M; Marafioti T; Anagnostopoulos I; Stein H
J Pathol; 1999 Jun; 188(2):133-8. PubMed ID: 10398155
[TBL] [Abstract][Full Text] [Related]
5. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
6. Analysis of immunoglobulin VH genes in CD10-positive diffuse large B-cell lymphoma.
Hojo H; Kuze T; Nakamura N; Hashimoto Y; Sasaki Y; Sato M; Shirakawa A; Abe M
Pathol Int; 2002 Sep; 52(9):586-94. PubMed ID: 12406188
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
10. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
Lu TX; Liang JH; Miao Y; Fan L; Wang L; Qu XY; Cao L; Gong QX; Wang Z; Zhang ZH; Xu W; Li JY
Sci Rep; 2015 Jul; 5():12168. PubMed ID: 26202875
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.
Cohen M; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Int J Cancer; 2014 Dec; 135(12):2816-24. PubMed ID: 24789501
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated composite lymphoma composed of peripheral T-cell lymphoma and an anaplastic variant of a diffuse large B-cell type of non-Hodgkin's lymphoma and strongly expressing p53 protein.
Hirose Y; Fukushima T; Masaki Y; Shimoyama K; Karasawa H; Ogawa N; Wano Y
Int J Hematol; 2004 Apr; 79(3):260-5. PubMed ID: 15168595
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma.
Nakamura N; Hashimoto Y; Kuze T; Tasaki K; Sasaki Y; Sato M; Abe M
Lab Invest; 1999 Aug; 79(8):925-33. PubMed ID: 10462030
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer.
Ikeda T; Gion Y; Sakamoto M; Tachibana T; Nishikori A; Nishimura MF; Yoshino T; Sato Y
Mod Pathol; 2020 Dec; 33(12):2437-2448. PubMed ID: 32561847
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]